A large increase in survival paralleled a doubling in bystander CPR over a 10-year period.
New recommendations for cardiopulmonary resuscitation (CPR) technique and widespread deployment of automated external defibrillators (AEDs) have changed the resuscitation landscape. A decade ago, research in Denmark identified very low rates of bystander CPR. In response, several national initiatives were implemented to promote bystander resuscitation attempts. Using a database of cardiac arrest cases in Denmark, researchers assessed changes in bystander CPR, use of AEDs, and survival, from 2001 to 2010.
The study included nearly 20,000 cases of cardiac arrest with cardiac etiology that were not witnessed by emergency medical services personnel. During the study period, bystander CPR increased from 21% to 45% of cases, survival to hospital a…
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals